Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome
Clinical trial NCT02739217 · COMPLETED
Trial details
- NCT number
- NCT02739217
- Sponsor
- Liminal BioSciences Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-22
- Primary completion
- 2017-09-26
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.